AZD2171 : A highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
WEDGE, Stephen R ; KENDREW, Jane ; CHESTER, Rosemary ; JACKSON, Janet A ; BOFFEY, Sarah J ; KILBURN, Lyndsey L ; BARNETT, Sharon ; RICHMOND, Graham H. P ; WADSWORTH, Peter F ; WALKER, Mike ; BIGLEY, Alison L ; TAYLOR, Sian T ; HENNEQUIN, Laurent F ; COOPER, Lee ; BECK, Sarah ; JÜRGENSMEIER, Juliane M ; OGILVIE, Donald J ; VALENTINE, Paula J ; BARRY, Simon T ; BRAVE, Sandra R ; SMITH, Neil R ; JAMES, Neil H ; DUKES, Michael ; CURWEN, Jon O
Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4389-4400 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer Research
Texto completo disponível